These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7201815)

  • 21. [Use of a feprazone-bromhexine combination in acute and chronic bronchopneumopathies].
    Alessandrini A; Bianchi RM; Geromino A; Negri L
    Clin Ter; 1983 Nov; 107(3):185-91. PubMed ID: 6362963
    [No Abstract]   [Full Text] [Related]  

  • 22. [Infulence of pyrasanone on the index of articular radioisotope (tc99m) uptake in rheumatoid arthritis].
    Grimaldi MG; Bonora R
    Minerva Med; 1975 Sep; 66(56):2781-5. PubMed ID: 1174381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A double-blind cross-over trial of Prenazone (DA 2370) and phenylbutazone in rheumatoid arthritis.
    Reynolds PM; Sturrock RD; Isaacs A; Hart FD
    Rheumatol Rehabil; 1975 May; 14(2):67-70. PubMed ID: 1096276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemical characterization of decomposition products of pyrazolidinedione-3,5 derivatives. Part 2: Chemical transformations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (prenazone) and its main decomposition product N,N'-diphenylhydrazide-2-carboxy-5-methyl-4-hexenoic acid in sulphuric acid concentrated.
    Wachowiak R
    Arzneimittelforschung; 1979; 29(5):725-7. PubMed ID: 582968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical result of the treatment of chronic rheumatoid arthritis by non-steroidal anti-inflammatory agent, clofezone. Comparative study with phenylbutazone in a double-blid study at several clinics].
    Kageyama T
    Ryumachi; 1976 Mar; 16(1):85-99. PubMed ID: 135360
    [No Abstract]   [Full Text] [Related]  

  • 26. [The feprazone-bromhexine association in pediatric bronchopneumopathies].
    Pennacchio G; Manfredi G
    Minerva Pediatr; 1978 Aug; 30(15):1265-70. PubMed ID: 703705
    [No Abstract]   [Full Text] [Related]  

  • 27. Gastrointestinal blood loss on phenylbutazone and feprazone.
    Macfarlane JD; Maisey MN; Grahame R; Burry HC
    Rheumatol Rehabil; 1976 May; 15(2):108-11. PubMed ID: 132693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Some studies of feprazone.
    Haslock I; Burkinshaw L; Berry DJ; Donovan B; Wright V
    Rheumatol Rehabil; 1976 May; 15(2):81-6. PubMed ID: 132695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Niflumic acid in otorhynolaryngologic inflammation in childhood. Controlled study versus feprazone].
    Tarantino V; Stura M; Cremonesi G
    Minerva Pediatr; 1985 Oct; 37(20):827-32. PubMed ID: 3912657
    [No Abstract]   [Full Text] [Related]  

  • 30. [Thermographic evaluation of anti-inflammatory treatments in rheumatoid arthritis].
    Ring EF; Collins AJ; Bacon PA
    Rev Rhum Mal Osteoartic; 1975 Feb; 42(2):131-3. PubMed ID: 1129584
    [No Abstract]   [Full Text] [Related]  

  • 31. [Controlled clinical trial with ibuprofen and phenylbutazone in patients with rheumatoid arthritis].
    Vojtísek O; Brémová A; Hándlová D; Kanková D; Malecek J; Pavelka K; Susta A
    Fysiatr Revmatol Vestn; 1972 Aug; 50(4):214-21. PubMed ID: 5066147
    [No Abstract]   [Full Text] [Related]  

  • 32. Feprazone, a new anti-inflammatory agent. Studies of potency and gastrointestinal tolerance.
    Fletcher MR; Loebl W; Scott JT
    Ann Rheum Dis; 1975 Apr; 34(2):190-4. PubMed ID: 1094965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolites of feprazone in man.
    Yamaguchi H; Kubo J; Sekine K; Naruchi T; Hashimoto Y; Kato R
    Drug Metab Dispos; 1979; 7(5):340-4. PubMed ID: 40778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemical characterization of decomposition products of pyrazolidinedione-3,5 derivatives. Part 1: Identification of decomposition products and mechanism of degradation of 4-prenyl-1,2-diphenyl-3,5-pyrazolidine-dione in an aqueous solution.
    Wachowiak R
    Arzneimittelforschung; 1979; 29(4):599-602. PubMed ID: 582752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The thermographic assessment of inflammation and anti-inflammatory drugs in osteoarthritis.
    Ring EF; Dieppe PA; Bacon PA
    Br J Clin Pract; 1981; 35(7-8):263-4. PubMed ID: 7032564
    [No Abstract]   [Full Text] [Related]  

  • 36. Functional and clinical evaluation of feprazonebromhexine association in bronchopulmonary diseases.
    Del Bono N; Quartieri F; Renda B; Sconosciuto F; Vibelli C
    Panminerva Med; 1978; 20(2):117-22. PubMed ID: 360150
    [No Abstract]   [Full Text] [Related]  

  • 37. Gas-chromatographic analysis of 4-prenyl-1,2-diphenyl-3-5-pyrazolidinedione (feprazone) at therapeutic levles in human plasma.
    Berry DJ
    J Chromatogr; 1975 Nov; 114(1):159-65. PubMed ID: 241756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Controlled clinical trial with Benetazone (Spofa) during spa treatment].
    Susta A; Pavelka K; Bremová A; Salavcová V; Svandová H; Richter M
    Fysiatr Revmatol Vestn; 1975 Feb; 53(1):3-11. PubMed ID: 1092603
    [No Abstract]   [Full Text] [Related]  

  • 39. Somatostatin 14 and joint inflammation: evidence for intraarticular efficacy of prolonged administration in rheumatoid arthritis.
    Fioravanti A; Govoni M; La Montagna G; Perpignano G; Tirri G; Trotta F; Bogliolo A; Ciocci A; Mauceri MT; Marcolongo R
    Drugs Exp Clin Res; 1995; 21(3):97-103. PubMed ID: 7555618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A reevaluation of aspirin therapy in rheumatoid arthritis.
    Fries JF; Ramey DR; Singh G; Morfeld D; Bloch DA; Raynauld JP
    Arch Intern Med; 1993 Nov; 153(21):2465-71. PubMed ID: 8215751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.